The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants

被引:65
|
作者
Mowry, B. J. [1 ,2 ]
Gratten, J. [1 ]
机构
[1] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia
[2] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
CNV; functional genomics; GWAS; schizophrenia; sequencing; SNP; GENOME-WIDE ASSOCIATION; COPY NUMBER VARIANTS; 3Q29 MICRODELETION SYNDROME; INDIVIDUAL GENETIC RISK; PLURIPOTENT STEM-CELLS; BIPOLAR DISORDER; SUSCEPTIBILITY LOCI; PSYCHOTIC ILLNESS; NICOTINIC AGONIST; BRAIN-DEVELOPMENT;
D O I
10.1038/mp.2012.34
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
After decades of halting progress, recent large genome-wide association studies (GWAS) are finally shining light on the genetic architecture of schizophrenia. The picture emerging is one of sobering complexity, involving large numbers of risk alleles across the entire allelic spectrum. The aims of this article are to summarize the key genetic findings to date and to compare and contrast methods for identifying additional risk alleles, including GWAS, targeted genotyping and sequencing. A further aim is to consider the challenges and opportunities involved in determining the functional basis of genetic associations, for instance using functional genomics, cellular models, animal models and imaging genetics. We conclude that diverse approaches will be required to identify and functionally characterize the full spectrum of risk variants for schizophrenia. These efforts should adhere to the stringent standards of statistical association developed for GWAS and are likely to entail very large sample sizes. Nonetheless, now more than any previous time, there are reasons for optimism and the ultimate goal of personalized interventions and therapeutics, although still distant, no longer seems unattainable. Molecular Psychiatry (2013) 18, 38-52; doi:10.1038/mp.2012.34; published online 1 May 2012
引用
收藏
页码:38 / 52
页数:15
相关论文
共 35 条
  • [1] The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants
    B J Mowry
    J Gratten
    Molecular Psychiatry, 2013, 18 : 38 - 52
  • [2] Functional Validation of the Impact of Rare and Common Variants to Schizophrenia Risk
    Brennand, Kristen
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S74 - S75
  • [3] Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia
    Ishizuka, Kanako
    Yoshida, Tomoyuki
    Kawabata, Takeshi
    Imai, Ayako
    Mori, Hisashi
    Kimura, Hiroki
    Inada, Toshiya
    Okahisa, Yuko
    Egawa, Jun
    Usami, Masahide
    Kushima, Itaru
    Morikawa, Mako
    Okada, Takashi
    Ikeda, Masashi
    Branko, Aleksic
    Mori, Daisuke
    Someya, Toshiyuki
    Iwata, Nakao
    Ozaki, Norio
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2020, 12 (01)
  • [4] Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia
    Kanako Ishizuka
    Tomoyuki Yoshida
    Takeshi Kawabata
    Ayako Imai
    Hisashi Mori
    Hiroki Kimura
    Toshiya Inada
    Yuko Okahisa
    Jun Egawa
    Masahide Usami
    Itaru Kushima
    Mako Morikawa
    Takashi Okada
    Masashi Ikeda
    Aleksic Branko
    Daisuke Mori
    Toshiyuki Someya
    Nakao Iwata
    Norio Ozaki
    Journal of Neurodevelopmental Disorders, 2020, 12
  • [5] Mining the LIPG Allelic Spectrum Reveals the Contribution of Rare and Common Regulatory Variants to HDL Cholesterol
    Khetarpal, Sumeet A.
    Edmondson, Andrew C.
    Raghavan, Avanthi
    Neeli, Hemanth
    Jin, Weijun
    Badellino, Karen O.
    Demissie, Serkalem
    Manning, Alisa K.
    DerOhannessian, Stephanie L.
    Wolfe, Megan L.
    Cupples, L. Adrienne
    Li, Mingyao
    Kathiresan, Sekar
    Rader, Daniel J.
    PLOS GENETICS, 2011, 7 (12)
  • [6] Identification of rare and common variants in BNIP3L: a schizophrenia susceptibility gene
    Juan Zhou
    Chuanchuan Ma
    Ke Wang
    Xiuli Li
    Xuemin Jian
    Han Zhang
    Jianmin Yuan
    Jiajun Yin
    Jianhua Chen
    Yongyong Shi
    Human Genomics, 14
  • [7] Identification of rare and common variants in BNIP3L: a schizophrenia susceptibility gene
    Zhou, Juan
    Ma, Chuanchuan
    Wang, Ke
    Li, Xiuli
    Jian, Xuemin
    Zhang, Han
    Yuan, Jianmin
    Yin, Jiajun
    Chen, Jianhua
    Shi, Yongyong
    HUMAN GENOMICS, 2020, 14 (01)
  • [8] Identification of VIPR2 rare and common variants in the Chinese Han population with schizophrenia
    Yin, Jiajun
    Zhou, Juan
    Fang, Fang
    Yu, Shui
    Wang, Jun
    Yuan, Jianmin
    Zhou, Zhenhe
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [9] Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha
    Carroll, L. S.
    Williams, N. M.
    Moskvina, V.
    Russell, E.
    Norton, N.
    Williams, H. J.
    Peirce, T.
    Georgieva, L.
    Dwyer, S.
    Grozeva, D.
    Greene, E.
    Farmer, A.
    McGuffin, P.
    Morris, D. W.
    Corvin, A.
    Gill, M.
    Rujescu, D.
    Sham, P.
    Holmans, P.
    Jones, I.
    Kirov, G.
    Craddock, N.
    O'Donovan, M. C.
    Owen, M. J.
    MOLECULAR PSYCHIATRY, 2010, 15 (11) : 1101 - 1111
  • [10] Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha
    L S Carroll
    N M Williams
    V Moskvina
    E Russell
    N Norton
    H J Williams
    T Peirce
    L Georgieva
    S Dwyer
    D Grozeva
    E Greene
    A Farmer
    P McGuffin
    D W Morris
    A Corvin
    M Gill
    D Rujescu
    P Sham
    P Holmans
    I Jones
    G Kirov
    N Craddock
    M C O'Donovan
    M J Owen
    Molecular Psychiatry, 2010, 15 : 1101 - 1111